NASDAQ:EFTR

Effector Therapeutics Stock Signals

etoro logo Buy EFTR
*Your capital is at risk
$0.0006
+0 (+0%)
At Close: Jul 13, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for eFFECTOR Therapeutics, Inc.

General

Signal Type Signal Value Data
Score 0.000 113 days ( -200.00 %
Last Price $0.0006 0 %
Performance History
7 Days
$0.0006 $0.0006
0%
30 Days
$0.0002 $0.0006
200.00%
12 Mos
$0.0002 $0.0006
200.00%

9/18

Active Buy Signals

Specific Signals

Short Term
Net score: 64.19
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0006 - $0.0006
Trend - 3 mos 64.56 % High Width: 128.11 %
Pred. range - 3 mos $0.0005 - $0.0012 Low -13.38 % - 97.60 %
Volume Direction Sell High Volume: 154 · Direction: 0
Pivot Short Sell Very Low Jul 10, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Jul 10, 2026 - 2 days
Short MA 3 mos Buy Low Jun 25, 2026 - 12 days
Long MA 3 mos Buy Medium Jun 25, 2026 - 12 days
Short/Long MA 3 mos Buy Medium Jun 30, 2026 - 9 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 65.75
Signal Type Signal Value Importance Data
Trend - 12 mos -0.90 % Very High Width: 16,461.34 %
Pred. range - 12 mos N/A - $1.48 High -100.00 % - 246,124.45 %
Short MA 12 mos Buy Very High Jun 25, 2026 - 12 days
Long MA 12 mos Buy Very High Jun 25, 2026 - 12 days
Short/Long MA 12 mos Buy Very High May 11, 2026 - 43 days
Pivot Long Sell Low Jul 10, 2026 - 2 days
RSI Long Pivot Signal Buy Low Jul 06, 2026 - 6 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT EFFECTOR THERAPEUTICS, INC.
eFFECTOR Therapeutics
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit euk...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE